Danielle Maren Press, MD

Minesh Mehta, M.D., is chief of radiation oncology and deputy director of Baptist Health Miami Cancer Institute and a widely renowned expert in radiation oncology, proton therapy and cancer research. Dr. Mehta received his medical degree with highest honors from the University of Zambia School of Medicine. He completed a residency at the University of Wisconsin, where he was later appointed chairman of the medical school’s Department of Human Oncology.As part of his leadership efforts, he directed research studies, technology development and the expansion at the University of Wisconsin Cancer Center. He also headed its brain tumor program for more than 15 years, leading to his national leadership role in clinical trial research. Dr. Mehta has designed and led numerous national and international clinical studies, receiving National Institutes of Health and National Cancer Institute grants and winning honors for his research in brain and central nervous system tumors. He helped launch and was the medical director of the Maryland Proton Treatment Center in Baltimore, prior to joining Baptist Health. He is board-certified in radiation oncology by the American Board of Radiology and in neuro-oncology by the United Council for Neurologic Subspecialties. He has held national leadership positions in numerous organizations including the American Board of Radiology, the FDA Radiological Devices Panel, the American Society for Radiation Oncology, the American Society of Clinical Oncology and the Society of Neuro-Oncology.An avid researcher, Dr. Mehta provides a multidisciplinary, innovative approach to individual care and helps all his patients understand their diagnosis, available treatment options and potential clinical trials.

Meghan Crawley, M.D., is a head and neck surgical oncologist at Miami Cancer Institute, a part of Baptist Health South Florida. Dr. Crawley specializes in head and neck surgery and reconstruction. She has extensive experience in robotic surgical techniques and facial nerve reanimation for patients who require reconstruction of facial function. Dr. Crawley joined Miami Cancer Institute from the Cleveland Clinic Foundation, where she completed a fellowship in head and neck oncology and microvascular reconstructive surgery. Her research has been featured in several peer-reviewed publications, including Otolaryngology–Head and Neck Surgery, The Laryngoscope, Diabetes Care, Gastroenterology and the Annals of Otology, Rhinology, and Laryngology. In 2017, she was awarded the American Academy of Otolaryngology-Head and Neck Surgery’s Humanitarian Travel Grant for mission work in Haiti. During this medical mission trip, Dr. Crawley treated patients with advanced thyroid disease and oral cavity tumors. Dr. Crawley’s approach to patient care is to treat patients the way she would want herself or her family members to be treated. Having experienced caring for a loved one with cancer, she understands the stress and anxiety that comes with diagnosis, treatment and care. She hopes to be a strong support for her patients and their families. When she is not treating patients, Dr. Crawley enjoys long-distance running, paddle boarding, skiing, hiking, cooking and traveling.

Murugesan Manoharan, M.D., FRACS, is a surgical urologic oncologist and the chief of urologic oncology surgery at Miami Cancer Institute. Dr. Manoharan specializes in the treatment of genitourinary cancers, including bladder, kidney, prostate and testicular cancer. Dr. Manoharan also serves as the chairman of the Department of Urology at Baptist Health South Florida and a professor of urology at Herbert Wertheim College of Medicine, Florida International University.In 2022, the Abbhi Family Endowed Chair in Urologic Oncology was created to help Dr. Manoharan and the Institute conduct research and clinical trials to improve survival rates and quality of life for patients with bladder cancer.He joined Miami Cancer Institute from the Sylvester Comprehensive Cancer Center, where he served as one of the site disease group leaders for genitourinary cancers. He also practiced urology at Jackson Memorial Hospital and the Veterans Affairs Medical Center in Miami.Dr. Manoharan is a renowned leader in the treatment of prostate cancer, kidney cancer, bladder cancer and other urologic malignancies. He is an expert in minimally invasive surgery, including nerve sparing robotic prostatectomy, robotic kidney surgery, robotic bladder removal and neobladder reconstruction. Dr. Manoharan was one of the first urologists in the United States to perform robotic bladder removal surgery and reconstruction of neobladder using a Pfannenstiel incision. He also specializes in other minimally invasive ablative cancer procedures, such as high-intensity focused ultrasound (HIFU) therapy, cryotherapy and the NanoKnife procedure to treat prostate cancer. He has extensive experience training medical students, residents and oncology fellows. He has won numerous awards for his teaching and clinical excellence, as well as his research work. Dr. Manoharan’s research interests include stem cell applications, biomarkers and cancer outcomes. He serves as an editorial reviewer for several scientific publications. He is also widely published in peer-reviewed medical journals and is an invited speaker at national and international scientific symposiums. Dr. Manoharan has authored more than 140 scientific articles and 15 textbook chapters and has presented papers and posters at more than 100 national and international meetings. He served as vice chairman and a member of the International Bladder Cancer Guidelines committee, organized by the WHO and Société Internationale d'Urologie.When he is not treating patients, Dr. Manoharan enjoys music and traveling.